Dean L. Schorno, Chief Financial Officer of Genomic Health, - adios Brad steps in
On June 13, 2014, Dean L. Schorno, Chief Financial Officer of Genomic Health, Inc. (the "Company"), notified the Company that he would be resigning from his position to pursue a chief financial officer opportunity with a privately held company. Mr. Schorno will remain available for consultation during a transition period.
(c) The Company's Board of Directors has appointed G. Bradley Cole, the Company's Chief Operating Officer, to serve in the additional positions of Chief Financial Officer and principal financial and accounting officer effective June 19, 2014. Mr. Cole, age 58, has served as the Company's Chief Operating Officer since January 2009, and also served as the Company's Chief Financial Officer from July 2004 until January 2011. Mr. Cole has no family relationships with any of the Company's directors or executive officers, and he has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.
The Company intends to conduct a search for a new Chief Financial Officer.